Tenzing Acquisition in an 8-K filing today said shareholders voted to merge with pharmaceuticals company Reviva. The deal gives the combined company a valuation of $119 million. Read more.
Shareholders Approve Tenzing/Reviva Merger
Related Posts
Bright Lights Acquisition Amends $200M IPO Prospectus
The SPAC said it will focus on companies that can benefit from celebrity ownership and/or partnership.
LightJump Acquisition Merging with Moolec Science in $504M Deal
Moolec is engaged in molecular farming for the new food industry that uses plants to produce animal proteins.
Crixus BH3 Acquisition Wins 6-Month Extension as Redemptions Hit 63%
Crixus BH3 raised $200 million in an October 2021 IPO to focus on businesses that manage, finance, operate, construct, control, own or support real estate.
Consumer-Focused bleuacacia Adds Another NRA
The agreement was secured the same day the SPAC's shareholders voted in favor of a deadline extension to Nov. 22.